Utah State University

DigitalCommons@USU
All Graduate Theses and Dissertations

Graduate Studies

5-2021

Effect of Dietary Short and Medium Chain Fatty Acids in Murine
Lethal Sepsis Model
David Son Dang
Utah State University

Follow this and additional works at: https://digitalcommons.usu.edu/etd
Part of the Dietetics and Clinical Nutrition Commons

Recommended Citation
Dang, David Son, "Effect of Dietary Short and Medium Chain Fatty Acids in Murine Lethal Sepsis Model"
(2021). All Graduate Theses and Dissertations. 8052.
https://digitalcommons.usu.edu/etd/8052

This Thesis is brought to you for free and open access by
the Graduate Studies at DigitalCommons@USU. It has
been accepted for inclusion in All Graduate Theses and
Dissertations by an authorized administrator of
DigitalCommons@USU. For more information, please
contact digitalcommons@usu.edu.

EFFECT OF DIETARY SHORT AND MEDIUM CHAIN FATTY ACIDS IN
MURINE LETHAL SEPSIS MODEL
by
David Son Dang
A thesis submitted in partial fulfillment
of the requirements for the degree
of
MASTER OF SCIENCE
in
Nutrition, Dietetics and Food Sciences

Approved:

______________________
Robert E. Ward
Major Professor

____________________
Korry Hintze
Committee Member

______________________
Donald J. McMahon
Committee Member

____________________
D. Richard Cutler, Ph.D.
Interim Vice Provost of Graduate Studies

UTAH STATE UNIVERSITY
Logan, Utah
2021

ii

Copyright © David Dang 2021
All Rights Reserved

iii

ABSTRACT

Effect of Dietary Short and Medium Chain Fatty Acids in Murine Lethal Sepsis
Model
by
David Dang, Master of Science
Utah State University, 2021

Major Professor: Dr. Robert E. Ward
Department: Nutrition, Dietetics, and Food Science
The objective of this study was to determine the effects of dietary short and
medium chain fatty acids in on the stress-induced inflammatory response using a
murine lipopolysaccharide (LPS) model. It was hypothesized that a diet containing
short and medium chain dietary fatty acids would be protective, in terms of survival,
against lipopolysaccharide induced inflammation.
Mice were fed a purified AIN-76A diet that either contained corn oil, anhydrous
milk fat, a combination of corn oil with milk fat globule membrane or medium chain
triglyceride oil, or a milk fat globule membrane and anhydrous milk fat combination
(5% by weight). Diets were balanced to contain the approximately the same amount of
macro- and micronutrients and only differ in fat source. After being on the diet for 7
weeks, mice were challenged by intraperitoneal injection, with LPS (10 mg/kg) or
saline. Primary endpoints for this experiment were: survival, intestinal permeability,
production of proinflammatory cytokines, and histopathology of the large intestine.
No significant differences were found with weight gain and body mass
measurement. Diet did not affect fasting glucose or glucose sensitivity. Within 30 hours
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of LPS injection there was 0% survival of all mice across all diets. LPS challenge
caused hyperpermeability of the gut compared to sham mice. Also, LPS challenge
increased proinflammatory cytokines. In conclusion, the current data indicates that the
addition of dietary fats that are high in short and medium chain fatty acids to a purified
diet may not have a protective effect against LPS-induced inflammation.
(50 pages)
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PUBLIC ABSTRACT

Effect of Dietary Short and Medium Chain Fatty Acids in Murine Lethal Sepsis
Model
David Dang

Sepsis is defined as the presence of an infection in combination with systemic
inflammation in a host. One of the detrimental results of sepsis is multiple organ failure
which eventually leads to death. Lipopolysaccharide (LPS), an endotoxin that can be
found on the outer surface of gram-negative bacteria, can be used as a model for sepsis.
LPS present in the circulatory system of hosts can induce symptoms that are seen in
patients during septicemia.
Previous studies have suggested that including milk fat in a diet may protect
against a lethal dosage of LPS in rodents. Milk fat has a unique fatty acid composition
in which approximately 20-30% is made up of short and medium chain fatty acids.
Interestingly, studies have also indicated that medium chain triglyceride (MCT) oil can
also have a protective effect against LPS induced inflammation. The objective of this
research was to determine if these dietary fatty acids, would have any effect against
inflammation that is induced by LPS using an animal model.
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CHAPTER 1
INTRODUCTION
Sepsis is defined as the presence of an infection in combination with systemic
inflammation in a host (Nguyen et al., 2006). One of the detrimental results of sepsis is
multiple organ failure which eventually leads to death. Indicators of systemic
inflammation include irregular body temperature ( >38ºC or < 36ºC), a high pulse rate
(>90bpm), and either a very high or low white blood cell count (Nguyen et al., 2006).
During sepsis, the host response begins to activate monocytes, macrophages, and
neutrophils that interact with endothelial cells through numerous pathogen recognition
receptors (Beutler, 2004). Furthermore, the cellular activation allows for the
mobilization of plasma cytokines which include tumor necrosis factor, interleukins, and
eicosanoids (Nguyen et al., 2006). The mechanism behind sepsis is unclear and there is
currently no known preventative measure or treatment for the illness. However, recent
studies have suggested that short and medium chain fatty acids may play a role in
protecting against septicemia (Kono et al., 2003, Snow et al., 2011). One source of these
types of saturated fatty acids is dairy fat.
In the past, epidemiological data have linked the consumption of saturated fats
to certain cardiovascular diseases such as coronary heart disease (Hu et al., 1999).
However, in the last few years, scientists have begun to question whether dairy fats
should be categorized with other sources of saturated fat, as more recent
epidemiological studies suggest that dairy consumption is inversely related to
metabolic diseases such as Type 2 diabetes (T2D) (Elwood et al., 2008, Tong et al.,
2011, Kalergis et al., 2013, Hirahatake et al., 2014). The idea that dairy fat may protect
against the development of metabolic diseases is interesting since certain risk factors
that are associated with these diseases, such as insulin resistance, high levels of low-
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density lipoprotein cholesterol, elevated blood triglyceride levels, and increases in
inflammatory markers, are a concern in the U.S. population (Ervin, 2009, Mozaffarian
and Ludwig, 2015). Several different proposed mechanisms and pathways suggest that
the protective effect from dairy fat comes from a multitude of sources which includes
a calcium dependent pathway (Zemel, 2003a, b, Sun and Zemel, 2006, Sun and Zemel,
2008), its role in preventing mitochondrial dysfunction (Sun and Zemel, 2007, 2009,
Zemel and Zhao, 2009, Bruckbauer and Zemel, 2011, Li et al., 2012), and its supply of
a bioactive lipid (trans-palmitoleate)(Mozaffarian et al., 2010, Mozaffarian et al.,
2013). Unlike most foods, dairy fat contains a relatively high amount of short and
medium chain saturated fatty acids.
Fatty acids are typically categorized by their carbon chain length and degree of
unsaturation. Medium and short chain fatty acids are saturated fatty acids typically 4 to
14 carbons long. Dairy fat contains this group of fatty acids along with other longer
chain fatty acids. The fatty acids in bovine milk come from two sources: de novo
synthesis or the diet. Medium and short chain fatty acids, which are present in milk fat
at up to 10.9% (Månsson, 2008), are metabolized differently than longer chain fatty
acids. The metabolism of fats begins in the intestine, where triglycerides are broken
down to free fatty acids by pancreatic lipases and bile salts. Longer chain free fatty
acids are reesterified into triglycerides and packed in chylomicron vesicles and are
transported into the lymphatic and circulatory system. Unlike longer chained fatty
acids, medium and short chain fatty acids act as free molecules that can be transported
directly to the liver via the portal vein (Figure 1).
The long-term goal of this proposed project is to investigate the potential health
effects of short and medium chain fatty acids. This research will examine the roles of
fats in the diet, specifically, the role of short and medium chain saturated fatty acids
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found in dairy fat and medium chain triglyceride oil (MCT) in a model for sepsis. If
they are shown to have a protective effect, further studies of these dietary fats would be
warranted.

Figure 1. Metabolism of SCFA/MCFA. MCTs are more rapidly absorbed compared
to longer chain triglycerides, which require a transport lipoprotein to pass through the
lymphatic system and a carnitine-dependent pathway at the hepatic site.
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CHAPTER 2
LITERATURE REVIEW
Gut permeability, intestinal microflora, and Gut-Liver Axis
It has been suggested that gut leakiness plays a role in allowing endotoxins to
enter the blood and activate cellular macrophages, monocytes, and neutrophils (Rao,
2009). A key component of the gastrointestinal tract is a layer of epithelial cells that
separate the body from the external environment. The epithelial layer is one way the
body ensures protection from a variety of environmental pathogens entering the blood
capillary system and causing an immune response (Arrieta et al., 2006). Specifically,
the small intestine epithelial cells regulate the transportation of materials between the
lumen and extracellular space. The movement of molecules through the small intestine
membrane can come from either transcellular transport, which relies on active
transport, or movement through the paracellular space, which occurs solely via passive
diffusion. The integrity of tight junctions between adjacent epithelial cells have been
shown to regulate the amount of materials that can diffuse across the membrane (Arrieta
et al., 2006, Anderson and Van Itallie, 2009). The permeability of the gut is especially
important considering the gut microbiota and the number of microorganisms that can
leave the lumen and enter the bloodstream.
The gastrointestinal microflora is made up of a diverse community of
microorganisms. The roles that the intestinal microflora can play include the production
of short-chain fatty acids, synthesis of vitamins, and other metabolic contributions
(Bentley and Meganathan, 1982, Canny and McCormick, 2008). The absence of
intestinal microflora, shown in germ-free mice, causes the loss of these important
metabolic functions (Wostmann, 1981). However, the beneficial effects that come with
having a diverse gut microbiome have a limit. Residing on the outer cell membrane of
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gram-negative bacteria, which are found naturally in the gastrointestinal tract, is a
glycolipid called Lipopolysaccharide (LPS) (Thurman, 1998). LPS, which has been
shown to signal for the proinflammatory immune response and the cause of
endotoxemia, can be found in the gut lumen (Van Deventer et al., 1988). The
concentration of LPS increases in the gut during sepsis (Canny and McCormick, 2008),
thus, compromise of the intestinal barrier would allow for the passage of more
endotoxin into the bloodstream (Mei et al., 2016). The direct cause of gut leakiness is
still unknown. Endotoxemia has been associated with gut leakiness which was linked
to certain high-fat diets in obese patients (Rao, 2009, Zhong et al., 2015). Ethanolinduced intestinal permeability in mice showed higher levels of plasma endotoxin,
which was further exacerbated through oral administration of LPS (Lambert et al.,
2003). One of the targets of LPS is a CD14 LPS receptor that lies on the surface of
macrophages in the liver (Kono et al., 2003).
Kupffer cells are one of the resident macrophages that reside in the liver. The
main role of these cells is to remove endotoxins in the blood (Wheeler, 2003). In
response to the removal of endotoxins, Kupffer cells release proinflammatory cytokines
such as tumor necrosis factor-alpha (TNF-) (Dinarello, 2000). LPS has been shown
to be signal dependent on the membrane bound CD14 receptor on Kupffer cells (Kono
et al., 1998). Knockout of the receptor has been shown to slow the development of
metabolic diseases, which further indicates the involvement of LPS in developing
systemic inflammation (Cani et al., 2008). It has been reported that activated Kupffer
cells can be inhibited by gadolinium chloride (GdCl3), a compound toxic to Kupffer
Cells, thus preventing liver injury (Adachi et al., 1994). However, gadolinium chloride
is not suitable for clinical use due to its toxicity. Therefore, a better mechanism for
preventing injury via inhibition of activated Kupffer cells is needed.
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Diet and Inflammation
Diet has been shown to play a crucial role in the development and treatment of
chronic and acute inflammation in humans (Giugliano et al., 2006, Galland, 2010).
Dietary fat is one of the macronutrients that can be directly linked to inflammation. For
instance, a selection of important mediators of inflammation such as eicosanoids,
prostaglandin E2, and leukotriene B4, are all derived from the precursor omega-6 (6) poly-unsaturated fatty acid (PUFA), arachidonic acid (AA) (James et al., 2000). AA
is formed from the metabolism of linoleic acid, which is an essential fatty acid, through
a series of elongation and desaturation (Nakamura et al., 2004). Existing evidence
indicates that a diet with high dietary PUFAs concentration, depending on if it’s an
omega-3 (-3) or -6 fatty acid, can either decrease or exacerbate the inflammatory
responses. It was shown that biomarkers for inflammation such as proinflammatory
cytokines TNF- are higher in mice that consume an -6 rich diet using corn oil,
compared to an -3 enriched diet during infection (Ghosh et al., 2013). An increase in
other proinflammatory cytokines such IL-1, IL-6, IL-2 and IFN- are commonly
associated with linoleic acid rich diets due to arachidonic acid-derived eicosanoids
(Calder, 2001). Furthermore, mice fed a high -6 diet had elevated levels of
proinflammatory microbes in the gut and also severe intestinal damage during infection
(Ghosh et al., 2013). In contrast to the abundance of data that exists for PUFAs and
their roles in inflammation, little is known about the dietary fats in dairy and their
potential effects on markers of inflammation.
Milk Fat Globule Membrane
One of the unique components of milk is the milk fat globule membranes
(MFGM). Inside the mammary epithelial cells, triacylglycerol droplets are secreted
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from the rough endoplasmic reticulum, into the cytosol, with a phospholipid/cholesterol
monolayer. As the fat droplet migrates through the apical membrane of the cell, it is
coated with a triple phospholipid layer membrane, which consist of glycoproteins,
cholesterol, and phospholipids, and proteins. Phospholipids such as sphingomyelin,
phosphatidylcholine, and phosphatidylethanolamine, which comes from the membrane,
make up approximately 30% of the total lipid content of milk fat globules (Black et al.,
1998, Cavaletto et al., 2008, Hernell et al., 2016). The phospholipids in MFGM have
been shown to play a role in intestinal maturation, in which a decrease in lactase activity
and vacuolated enterocytes, which are located along the villi of the intestinal wall,
reflects the maturity of intestinal cells (Motouri et al., 2003). The beneficial effect it
has on gut integrity and proliferation of epithelial cells is seen most prominently during
the neonatal stages in animals and humans (Greenspon et al., 2009, Greenspon et al.,
2011). In a past study, a diet that consisted of fat coming from MFGM in combination
with milk fat improved gut epithelial integrity and prevented hyper-permeability in
mice during a state of acute inflammation induced by LPS (Snow et al., 2011). In this
study, mice that had a diet with MFGM as a source of fat had a lower concentration of
plasma fluorescence (which is used as an assessment of gut integrity) and survived 48
hours after administration of a lethal dosage of LPS compared to the control group
(Snow et al., 2011). It was suggested that the reduction in gut permeability ultimately
protected the mice from death after being given a possibly lethal dosage of LPS by
disallowing further release of inflammatory toxins that reside in the gut. Interestingly,
a study with a similar experimental design in which medium chain triglyceride (MCT)
oil was orally given to rats produced similar results in survival and intestinal
permeability. An increase in survival was seen as dose response to MCT and a decrease
HRP activity, which was used as an indicator for intestinal permeability, was seen in
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rats that had supplemented MCT oil (Kono et al., 2003). A dosage of 5g/kg of MCT
oil, was shown to be effective in preventing septic shock in this study. The similar result
between these two studies brings into consideration the possibility that the protective
effects from both diets comes from the similar fatty acid composition of the diets.
Short and Medium Chain Fatty acids
The production of short and medium chain fatty acids in dairy fat (which are
products of microbial activity in the rumen) has long been studied (McGuire and
Bauman, 2002, Parodi, 2009). The amount of saturated fatty acids make up
approximately 70% of the total weight of the fat in milk (Månsson, 2008). Of the
saturated fatty acids, about 11% are short chain fatty acids (SCFA) (Månsson, 2008).
SCFA are typically esterified at the sn-3 position on a triglyceride (Månsson, 2008).
When consumed by humans, milk triglycerides are digested by lipases in the stomach.
The preference for hydrolyzing at the sn-3 position of the triglyceride by lipases allows
for the release of the SCFA (Månsson, 2008). More specifically, dietary fats, more
specifically in the form of long-chain fatty acids, once hydrolyzed, are absorbed in
mixed micelles and are transported in chylomicrons (Kono et al., 2003). Unlike longchain fatty acids, short and medium chains fatty acids can be absorbed and transported
directly to the liver via the portal vein, where they are used for energy (Kono et al.,
2003). In one study, the metabolism of butyrate was shown to provide a positive effect
in an animal model by systemically reducing the expression of high-mobility group box
protein 1 (HMGB1) and also significantly increasing the survival rate of the treated
group compared to control during septic shock (Zhang et al., 2007). This positive effect
could be due to the direct absorption of the SCFA into the liver.
A series of studies have indicated that medium-chain triglyceride diets may
have protective effects against inflammation and promote insulin sensitivity. Diets
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supplemented with MCTs have been shown to suppress early alcohol-induced liver
injury, proinflammatory cytokines in endotoxin-challenged mice, and intestinal
inflammation in both animal and cell culture models (Hoshimoto et al., 2002, Mañé et
al., 2009, Carlson et al., 2015, Geng et al., 2016). It was reported that dietary MCTs
prevented alcoholic liver injury by inhibiting the activation of Kupffer cells (Kono et
al., 2003). It has also been shown that diets supplemented with MCTs improve glucose
tolerance in rats and diabetic patients, which suggests that MCTs may have antidiabetic benefits (Han et al., 2007, Terada et al., 2012). Findings from Kono et al.
(2003) have suggested that medium chain fatty acids play a direct role in inhibiting the
production of proinflammatory cytokines, which protects mice from septic shock and
death, through the down-regulation of macrophage surface receptor CD14 found in the
liver when given a lethal dosage of an endotoxin.
Overview
Both MCT and MFGM have a protective effect against mediators of sepsis.
What is missing in the literature is evidence that links these two entities together.
Therefore, this proposed study will evaluate the roles of short and medium chain fatty
acids in dairy fat and medium chain triglyceride oil. By using an animal model of sepsis,
we can test our hypothesis of SCFA/MCFA having a protective effect.
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CHAPTER 3
THE EFFECTS OF DIETARY MILK FAT AND MEDIUM CHAIN
TRIGLYCERIDE OIL DURING AN INFLAMMATORY REPONSE

The hypothesis of this proposed research is:
A purified diet with a fat composition coming from short and medium chain fatty
acids from dairy fat or medium chain triglyceride will protect against acute
inflammation induced by lipopolysaccharide.

The objective of this proposed research is:
1) Establish an animal model to determine the effects of dietary fatty acids on the
inflammatory response to lipopolysaccharide.
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Diet Formulation
For this study, five purified diets varied only in fat composition were formulated
(Envigo Teklad Diets, Madison, WI USA). The diets were based on the American
Institute of Nutrition -76A (AIN-76A) diet, which has a 5% by weight basis for its
dietary fat (Table 2). The macro- and micronutrients in the diets were adjusted to be
equivalent (Table 1). Each diet only differed in its type of dietary fat: corn oil (CO),
medium chain triglyceride oil + corn oil (MCT+CO), anhydrous milk fat (AMF), milk
fat globule membrane + corn oil (MFGM+CO), or milk fat globule membrane +
anhydrous milk fat (MFGM+AMF). The milk fat globule membrane isolates diet was
formulated previously in the Ward lab(Snow et al., 2011) in which 125 grams of the
isolate were used to have approximately 10% of the fat as phospholipid and the other
half being anhydrous milk fat (MFGM/AMF) which was shown to have a protective
effect against sepsis (Snow et al., 2011).
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Table 1. Composition of Diets

Corn Oil

Ingredients
Protein (g/kg of diet)
Casein
183
Whey Protein Isolate
17
DL-Methionine
3
Carbohydrate (g/kg of diet)
Sucrose
494.9
Cellulose
50
Lactose, monohydrate
5
Corn Starch
150
Fat
Corn Oil
50
Medium Chain Triglyceride
Oil
Anhydrous Milkfat
MFGM Powder
Vitamins and minerals (g/kg of diets)
Mineral Mix
35
Vitamin Mix
10
Choline Bitartrate
2
Ethoxyquin, antioxidant
0.01

Medium
Chain
Triglyceride
Oil + Corn
Oil

Anhydrous
Milk Fat

Milk Fat
Globule
Membrane
+ Corn Oil

Milk Fat
Globule
Membrane
+Anhydrous
Milk Fat

183
17
3

183
17
3

103
3

103
3

494.9
50
5
150

494.9
50
5
150

494.9
50
5
150

494.9
50
5
150

25

-

25

-

25

-

-

-

-

50
-

125

25
125

35
10
2
0.01

35
10
2
0.01

35
10
2
0.01

35
10
2
0.01

Table 2.Percentage of Macronutrients in the Diets
Corn
Oil

Protein
Carbohydrate
Fat

17.8
64.9
5.2

Medium
Chain
Triglyceride
Oil + Corn
Oil

17.8
64.9
5.2

Anhydrous
Milk Fat

17.8
64.9
5.2

Milk Fat Globule
Membrane +
Corn Oil

17.8
64.9
5.1

Milk Fat
Globule
Membrane
+Anhydrous
Milk Fat

17.8
64.9
5.1
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Mice Study 1
Animals and Preliminary Measures
BALB/c mice were randomly assigned to each diet (n=12) for 6 weeks. The
preliminary measures during this stage of the experiment included monitoring for
weight changes in the animal, body composition using Magnetic Resonance Imaging
(MRI), and glucose sensitivity by oral glucose tolerance test (OGTT). Weight was
measured weekly during the 6-week diet treatment. Body composition was measured
twice, at baseline prior to treatment and at terminal, before LPS challenge.
Oral Glucose Tolerance Test
An OGTT was conducted at the end of the 6-week treatment period before the
LPS challenge. OGTT was done by using a glucose monitoring system from a local
medical supplier. A stock solution of 200 mg/mL was made. Mice were gavaged with
a total of 2 g glucose/kg bodyweight. Blood was retrieved from the tail-end of the
animal via tail snip. Six mice were randomly selected from each group for this
procedure. Glucose was measured in triplicate at baseline, 15, 30, 60, 90, and 120
minutes, post glucose gavage.
Lipopolysaccharide Challenge
After 6 weeks, mice were injected (i.p.) with 10mg LPS/kg body weight to
induce septic shock. Six hours after LPS challenge, mice were sacrificed by CO2
asphyxiation and cardiac puncture. Serum, colon, liver, skeletal muscle, and visceral
adipose were collected and flash frozen. The remaining were monitored for 48 hours
for survival. A flow diagram of the process is presented in Figure 6.
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Monitor for survival (48
hours)
(n=24)
BALB/c
(n=48)
Sacrificed after 6 hours of
challenge
(n=24)

Necropsy for blood
samples and organs are
collected for evaluation
of systemic infllamation

Figure 2. Experimental design for mouse study 1. Mice (n=12) were divided into two
groups with an n=6 in each group. Mice that underwent an OGTT were selected as the
sacrificed group after LPS was challenged. This selection method was used to ensure
that the same treatment was conducted on each mouse within both groups. Six hours
after the challenge, samples were collected.
Evaluation of gut barrier integrity in mice and colon inflammation
Mice that were assigned to be sacrificed were gavage with Fluorescein
Isothiocyanate –dextran (FITC-dextran ~4,000 Da) (600mg/kg body weight,
60mg/mL) to assess gut permeability. The oral gavage of FITC-dextran was performed
at the same time as the LPS injection, 6 hours prior to sacrifice. FITC-dextran recovered
in the blood plasma was analyzed using a fluorescence plate reader at (excitation)
=493 nm and (emission) = 517 nm. and was used to assess the integrity of the gut in
the animals.
Colons were cleaned with 1X PBS, fixed with 70% ethanol and then Swissrolled for storage for 24h in 10% formalin. After 24h of storage, 10% formalin was
replaced with 70% ethanol for final storage before histological analysis. Colons were
evaluated for inflammatory changes using a histologic scoring system described for
mouse small intestine (Rees, 1998, Burns et al., 2001). An overall inflammatory score
was given to each tissue which indicated the extent of lesions and inflammation.
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Statistical Analysis
A completely randomized design was used to evaluate the response of dietary
milk fat or medium chain triglyceride oil on mice when challenged with LPS. ShapiroWilk normality test was used to determine if data points were normally distributed. A
log-transformation was used for data points that were not normally distributed. Tukey’s
multiple comparisons were used for posthoc analysis. The analysis was performed with
GraphPad Software Prism 7 (GraphPad Software Inc., La Jolla, CA USA). Data is
displayed as mean  SEM.
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Results
Body Weight, Mass, and Food Intake
After being on the diet for 6 weeks, there were no significant differences
between the four groups. Lean and fat body mass were measured at baseline and at the
end. Feed efficiency was calculated as a ratio of the total food intake over kilocalories
for 6 weeks. No significant differences were noted in feed efficiency between each diet
group.

Figure 3. Weight and food intake measurements. An n=12 is assigned per group. A)
Change in body weight monitored for 6 weeks. No differences were seen after 6 weeks
of diet treatment. B) Feed efficiency was calculated as a ratio of the cumulative food
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intake over total kilocalories. C) and D) No significant differences were seen after 6
weeks on the diet.
Oral Glucose Tolerance Test
A measure of fasting glucose and an oral glucose tolerance test was conducted
to evaluate glucose sensitivity. The results indicate that a diet consisted of either milk
fat or MCT oil does not have any significant effect on glucose sensitivity relative to a
corn oil base diet.

Figure 4. Fasting glucose measurement and OGTT. Diet effect on fasting glucose and
glucose tolerance. An n=12 is assigned per group. A) Mean in concentration of
milligram per deciliter. Glucose measurements were taken during fasting prior to
OGTT. B) Area under the curve was calculated by the sum each area calculated by each
time point. (Baseline, 15min, 30min, 60min, 90min, and 120min). Triplicate
measurements of glucose concentration were made for each time point.
Survival
After LPS injection, mice were monitored for 48h for survival. Within the first
16h following the injection, mice on the CO, AMF, MCT+CO, and MFGM+CO groups
began to die due to the LPS challenge. In less than 24h, 90% of the animals had died.
By 24 h, there was 0% survival for the four groups.

18

Figure 5. Survival plot. An n=6 was assigned per group. Animals were monitored
everything 2-4 hours for 48h.
Intestinal inflammation and epithelial cell permeability
Histological analysis revealed no differences in colon histology scores for mice
on CO, AMF, MCT+CO, and MFGM+CO diets. The lesions in these mice consisted of
lymphocyte infiltration and aggregates within the submucosa and deep mucosa. The
colonic crypt and epithelium were intact. Since the mice in these groups did not survive,
it was expected to see a high score. There was no protective effect against intestinal
hyperpermeability, which was previously supported in past published literature.

19

Figure 6. Gut permeability and inflammation measurements. Effect of diets on
fluorescence and colon inflammation after LPS challenge. An n=6 is assigned per
group. A) Data are log10 transformed mean nanogram per milliliter. B) Inflammation
parameters were summed together and then multiplied by a factor reflecting the
percentage of the colon involved (0–25% (1), 26–50% (2), 51–75% (3), and 76–100%
(4), to obtain the overall score (up to 24). Severity and distribution were separately
assessed and combined into one score. Colon tissues of mice that were on the
MFGM+AMF diet that survived LPS challenge, were also submitted for histology.
Interestingly, inflammatory scores for these mice that survived had a delayed effect of
inflammation.
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Mice Study 2
Changes in dietary medium chain fatty acids in MCT+CO diet
Fatty acid composition analysis using gas chromatography on the diets detected
Capric acid (C10:0) in the MCT+CO diet. Previously, it was suggested that the
protective effect of medium chain fatty acids was due to Caprylic acid (C8:0) being in
the diet(Kono et al., 2003). As a result, for the second mice study, an isolated form of
the medium chain triglyceride oil, which only contained C8:0 was used to formulate
the MCT+CO diet.
Animals and Preliminary Measures
For this study, BALB/c mice were used (n=90). Mice were randomly assigned
to each diet (n=18) but were group housed in triplicates for 7 weeks. The preliminary
analyses during this stage of the experiment included monitoring for weight changes in
the animal, lean body mass and fat mass using MRI, and glucose sensitivity. Weight
was measured weekly during the 7-week treatment. Body composition was measured
twice, at baseline prior to treatment and at terminal, before LPS challenge.
Lipopolysaccharide and Sham Challenge
After 7 weeks, mice were injected (i.p.) with 10mg LPS/kg body weight to
induce septic shock (n=60). Mice that previously underwent an OGTT (n=30) were
given Sham injections. Of the total n=60 LPS challenged mice, n=30 were used for
survival analysis. Survival was monitored for 48h. Six hours after the challenge, both
Sham (n=30) and the remaining LPS (n=30) challenged mice were sacrificed by CO2
asphyxiation and cardiac puncture and serum, small and large intestines, and liver was
collected and flash frozen.
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Monitor for survival for
48h: LPS group (n=30)
BALB/c
(n= 90)
Sacrificed after 6 hours of
challenge: LPS (n=30)
and Sham (n=30) group

Necropsy for blood
samples and organs are
collected for evaluation
of systemic inflamation

Figure 7. Experimental design for mice study 2. Mice (n=90) will be divided into two
groups with survival group having a total of 30 sample size (n=6 per diet group) and a
total of 60 samples for the sacrificed group. 6 hours after challenge, sample collection
will occur for the sacrificed animal.
Evaluation of gastrointestinal and hepatic inflammation
Intestinal tissue was cleaned with 1X PBS, fixed with 70% ethanol and then
Swiss-rolled for storage for 24h in 10% formalin. After 24h of storage, 10% formalin
was replaced with 70% ethanol for final storage before histological analysis. Sections
of ileum, jejunum, colon, and liver were evaluated for inflammatory changes using a
histologic scoring system described for mouse small intestine (Rees, 1998, Burns et al.,
2001). An overall inflammatory score was given to each tissue which indicated the
extent of lesions and inflammation.
Analysis of proinflammatory cytokines in blood serum
Pro-inflammatory cytokines such as TNF-a, interleukin 1 (&), 12, and 18 are
released during an immune response (Netea et al., 2003). Previously, both MCT (Kono
et al., 2003) and MFGM (Snow et al., 2011) treatment resulted in a log reduction in the
concentration of these pro-inflammatory cytokines; thus, it is important to measure
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cytokine production for this study as well in order to see observe any similar findings.
Sixteen different cytokines were measured in serum using a Quansys-multiplex plate
reader: IL-1m IL-1, IL-2, IL-3, IL-4, IL5, IL6, IL-10, IL-12p70, IL-17, MCP-1,
IFN-, TNF-, MIP-1, GM-CSF, and RANTES. It has been shown that LPS has a
negative effect on gut integrity and increases the concentration of proinflammatory
cytokines (TNF-, IL-1, IL-6, and IL-12) in blood plasma.
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Statistical Analysis
A 2x2 factorial design was used to evaluate the response of dietary milk fat or
medium chain triglyceride oil on mice when challenged with LPS or Sham. ShapiroWilk normality test was used to determine if data points were normally distributed. A
log-transformation was used for data points that were not normally distributed. Tukey’s
multiple comparisons was used for posthoc analysis. The analysis was performed with
GraphPad Software Prism 7 (GraphPad Software Inc., La Jolla, CA USA). Data is
displayed as mean  SEM.
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Results
Body Weight, Mass, and Food Intake
Mice were fed the treatment diets for 7 weeks. Results indicated no significant
differences (P > 0.05) between diet groups in terms of body weight, feed efficiency,
and body mass.

Figure 8. Weight and food intake measurements. An n=6 is assigned per group. A)
Change in body weight monitored for 7 weeks. No significant differences were seen
after 7 weeks of diet treatment. B) Feed efficiency was calculated as a ratio of the
cumulative food intake over total kilocalories. C) and D) No significant differences
were seen after 7 weeks.
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Oral Glucose Tolerance Test
Contrary to what was seen previously in the preliminary study, blood glucose
concentration during fasting was not significantly different for mice on the
MFGM+AMF diet compared to other diets. Similarly, there were no significant
differences seen in any diet groups in terms of glucose tolerance.

Figure 9. Fasting glucose measurements and OGTT. Diet effect on fasting glucose and
glucose tolerance. A) Mean in concentration of milligram per deciliter. B) Area under
the curve was calculated by the sum each area calculated by each time point. (Baseline,
15min, 30min, 60min, 90min, and 120min). Triplicate measurements of glucose
concentration were made for each time point.
Survival
After LPS challenge, the survival of the groups was monitored for 48h. Within
18h, mice from the MCT+CO and AMF diets began to succumb to death from the LPS
challenge. At 24h, none of the mice fed with MCT+CO, AMF, MFGM+CO, and
MFGM+AMF survived. After 30h, there was 0% survival across all diet groups.
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Figure 10. Survival plot. An n=6 is assigned per group. Animals were monitored
everything 2-4 hours for 48h.
Intestinal inflammation and epithelial cell permeability
Although data are not presented here, histology conducted on the small
intestine, colon, and liver indicated that there were no significant differences seen in
the overall inflammation in these tissues. Surprisingly, there were no differences
between Sham and LPS treated mice. No significant differences in FITC-Dextran
concentration were seen between diet groups challenged with LPS. A lower
concentration of FITC-Dextran was seen in Sham mice compared to LPS mice.
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Figure 11. Gut permeability measurements. Effect of diets on fluorescence levels after
Sham or LPS challenge. An n=6 is assigned per group. Data are log10 transformed
mean nanogram per milliliter. No significant differences in fluorescence levels were
seen between any diets for LPS challenged mice.
Serum Cytokines Analysis
Sixteen different cytokines were analyzed which included: IL-1m IL-1, IL2, IL-3, IL-4, IL5, IL6, IL-10, IL-12p70, IL-17, MCP-1, IFN-, TNF-, MIP-1, GMCSF, and RANTES. Overall, LPS-challenged mice had a higher concentration of
plasma cytokines amongst all diet groups compared to Sham mice. Diets that were
predicted to reduce the production of pro-inflammatory cytokines (IL-1, IL-6, and
TNF-a) did not have any significant effects on the mice.
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Figure 12. Measurements of pro-inflammatory cytokines. Effect of dietary treatments
on serum cytokine concentration for Sham and LPS challenged mice. An n=6 is
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assigned per group. No significant differences were seen for all 17 serum cytokines in
LPS challenged mice.
Discussion
Intraperitoneal injection of LPS in a murine model is a method commonly used
for inducing gastrointestinal leakiness and systemic inflammation through the
production proinflammatory cytokines. It has been previously shown that certain
dietary fats, milk fat and medium chain triglyceride oil, can protect against acute
inflammation caused by LPS (Kono et al., 2003, Snow et al., 2011). Although these
dietary fats came from two completely different sources, they both contain either one
specific medium chain fatty acid (Caprylic C8:0) or a variety of short and medium chain
fatty acids (C4-C14). For this study it was hypothesized that short and medium chain
fatty acids in a purified diet will have a systemic protective effect against LPS.
However, our results indicate that these dietary fatty acids had no protective effect
against LPS in terms of survival, gut leakiness, or production of pro-inflammatory
cytokines. The experiment was designed to clarify an unanswered question that arose
in a previous study that suggested milk fat has a protective effect against
gastrointestinal leakiness and resilience to acute inflammation/septic shock. As
mentioned previously, it was unknown whether the milk fat globule membrane was the
source of that protection or it the anhydrous milk fat. Thus, a separate anhydrous milk
fat group was included in this study. At the same time, a diet that contained medium
chain triglyceride oil was also included in this design to further explore the possibility
that medium chain fatty acids could potentially be the reason to why these animals were
resilient to LPS.
Initially it was planned that a single study that involved the incorporation of
dietary fats coming from corn oil, MCT oil, and milk fat would be conducted. However,
after not seeing any treatment effect from mouse study 1, the study as reevaluated at it
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was discovered that there was a formulation error in the milk fat diet. The milk fat diet
was formulated to have a combination of MFGM and AMF, but CO was used instead.
Therefore, mice study 1 did not evaluate the effects of MFGM+AMF but instead it
looked at the effects of MFGM+CO during an inflammatory response. A separate single
trial run with one experimental group was then conducted, with the same parameter as
mice study 1, that had the correct milk fat formulation following mice study 1 (data not
shown). Mice that were in this trial survived an LPS challenge. Along with the
improvement in survival, the mice also had a lower concentration of serum FITCdextran and colon inflammatory score when compared to the experimental groups in
mice study 1. The trial run gave merit for repeating the entire study with the correct
diets.
In mouse study 2, a few alterations to the original design were made. A fatty
acid analysis of the previous MCT+CO diet indicated that both Caprylic (C8:0) and
Capric (C10:0) were present in the diet. Previously, another study with an MCT diet
containing only caprylic acid showed protective effects against LPS-induced shock.
This protection involved the down regulation of the CD14 LPS binding receptor located
on the surface of Kuppfer cell macrophages in the liver and alterations to intestinal
permeability. Thus, an MCT+CO diet without Capric acid was used in the second study.
After the finding from the colon histopathology from the trial experiment, we decided
to evaluate the jejunum and ileum to see if similar effects would be seen in proximal
region of the gastrointestinal tract. LPS also seemed to cause pathological changes in
the liver in which necrotic and hemorrhagic changes can occur (Kono et al., 2003), thus
segments of the liver were also taken for histopathological evaluation. In addition, a
sham challenged group was included in the design, as a negative control, to observe
any measurable differences for each test within diet groups.
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In the repeated study, LPS challenged mice did not survive regardless of diet
treatment (Figure 10). Mice were given purified diets for approximately the same
timeframe as the preliminary study. Weight gain, feed efficiency, and body mass
measurements indicated no significant differences between diet groups (Figure 8).
Fasting glucose concentration along with calculated area for OGTT were not
statistically different between diet group as well (Figure 9). LPS did influence gut
barrier dysfunction in which hyper-permeability was seen in LPS challenged mice
compared to the Sham (Figure 11). As expected, LPS challenged mice also had an
increase of inflammatory cytokines when compared Sham mice (Figure 12). However,
diets had no effect in preventing these negative effects from LPS.
The discrepancy in results from past results and published literature could have
stemmed from multiple factors. For instance, in the referenced study in which MCT
was shown to be effective in LPS challenged rats, the animals received capric acid
through oral gavage at dosage of 5mg/kg once a day. The mechanism of delivery by
oral gavage ensures that the test animals receive the required amount of dietary fats.
For this study, diets contained approximately 5% fat by weight and by allowing the
diets to be consumed ad libitum, mice were consuming less fat compared to the Kono
study. Thus, the lower intake in MCT could explain the lethality of LPS at a dosage of
10mg/kg. In the preliminary study, mice that were on the MFGM+AMF diet had a
significantly higher feed efficiency relative to the other diet groups for both preliminary
and repeated study, which indicates that these mice consumed more of the diet
compared to the other groups. Mice in the secondary study were also group housed due
to the large sample size, which can limit the amount of diet being consumed by each
individual mouse, and thus could have influence the experimental results.

33
Conclusion
Ultimately, the results from this research indicate that short and medium chain
fatty acids in a purified diet do not protect against acute inflammation induced by a
high dose of LPS. The fatty acids did not attenuate the hyper-permeability of gut and
release of the pro-inflammatory cytokines in LPS-challenged mice. Additionally, LPS
did not have any histopathological effect on the small intestine, large intestine, and
liver.
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